INS and metabolic dysfunction-associated steatotic liver disease: Pioglitazone treatment is also effective for improving insulin sensitivity and reducing NAFLD, but should only be considered when no other treatment options are available because of the well-established weight gain and other adverse effects associated with pioglitazone administration.